bankrupt 发表于 2025-3-21 17:08:43
书目名称Bisphosphonates and Tumor Osteolysis影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0188890<br><br> <br><br>书目名称Bisphosphonates and Tumor Osteolysis影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0188890<br><br> <br><br>书目名称Bisphosphonates and Tumor Osteolysis网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0188890<br><br> <br><br>书目名称Bisphosphonates and Tumor Osteolysis网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0188890<br><br> <br><br>书目名称Bisphosphonates and Tumor Osteolysis被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0188890<br><br> <br><br>书目名称Bisphosphonates and Tumor Osteolysis被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0188890<br><br> <br><br>书目名称Bisphosphonates and Tumor Osteolysis年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0188890<br><br> <br><br>书目名称Bisphosphonates and Tumor Osteolysis年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0188890<br><br> <br><br>书目名称Bisphosphonates and Tumor Osteolysis读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0188890<br><br> <br><br>书目名称Bisphosphonates and Tumor Osteolysis读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0188890<br><br> <br><br>wreathe 发表于 2025-3-21 23:33:25
http://reply.papertrans.cn/19/1889/188890/188890_2.png欢乐东方 发表于 2025-3-22 01:03:49
http://reply.papertrans.cn/19/1889/188890/188890_3.png外向者 发表于 2025-3-22 07:52:01
https://doi.org/10.1007/978-3-642-92439-2ey, breast, prostate, and ovary (Myers 1960). As therapeutic regimens in the treatment of malignant disorders have been improved in recent years, resulting in prolonged survival of patients, humoral hypercalcemia of malignancy has become a more frequent and often serious complication of tumor diseasApogee 发表于 2025-3-22 11:35:04
http://reply.papertrans.cn/19/1889/188890/188890_5.pngLasting 发表于 2025-3-22 16:39:35
http://reply.papertrans.cn/19/1889/188890/188890_6.png敬礼 发表于 2025-3-22 20:16:09
,Die Hornochschen Aufgaben (134–155),f these patients suffer from osteolytic bone metastases at some time during the course of their disease (Elte et al. 1986). Hypercalcemia is a frequent complication in patients with extensive lesions in the skeleton. Osteolytic bone metastases cause severe morbidity and often incapacitate the patienoverbearing 发表于 2025-3-23 01:10:57
Effect of Long-Term Bisphosphonate Treatment on Morbidity Due To Bone Metastases in Breast Cancer Pf these patients suffer from osteolytic bone metastases at some time during the course of their disease (Elte et al. 1986). Hypercalcemia is a frequent complication in patients with extensive lesions in the skeleton. Osteolytic bone metastases cause severe morbidity and often incapacitate the patients.气候 发表于 2025-3-23 02:45:02
https://doi.org/10.1007/978-3-642-83668-8bisphosphonates; bone; bone metastases; breast cancer; calcium; cancer; cancer research; carcinoma; metaboliMerited 发表于 2025-3-23 08:44:08
978-3-642-83670-1Springer-Verlag Berlin Heidelberg 1989